Apr 25, 2022

From Israeli lab: First AI-designed antibody enters clinical trials

Posted by in categories: biotech/medical, robotics/AI

Aulos Biosciences is now recruiting cancer patients in Australian medical centers for a trial of the world’s first antibody drug designed by a computer.

The computationally designed antibody, known as AU-007, was planned by the artificial intelligence platform of Israeli biotech company Biolojic Design from Rehovot, in a way that would target a protein in the human body known as interleukin-2 (IL-2).

The goal is for the IL-2 pathway to activate the body’s immune system and attack the tumors.

Leave a reply